Gene · 5698
Papers4,120
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 4,120
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies. | J Immunother Cancer | 2022 | 35764364 | PubTator, text mining | PubMed |
| The roles of DNA methylation on the promotor of the Epstein-Barr virus (EBV) gene and the genome in patients with EBV-associated diseases. | Appl Microbiol Biotechnol | 2022 | 35763069 | PubTator, text mining | PubMed |
| A transcriptome atlas and interactive analysis platform for autoimmune disease. | Database (Oxford) | 2022 | 35758882 | PubTator, text mining | PubMed |
| Thymus Functionality Needs More Than a Few TECs. | Front Immunol | 2022 | 35757725 | PubTator, text mining | PubMed |
| Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application. | Mol Ther Methods Clin Dev | 2022 | 35755947 | PubTator, text mining | PubMed |
| Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. | J Clin Immunol | 2022 | 35748970 | PubTator, text mining | PubMed |
| Hodgkin Lymphoma: Biology and Differential Diagnostic Problem. | Diagnostics (Basel) | 2022 | 35741318 | PubTator, text mining | PubMed |
| DNA Methylation Biomarkers for Prediction of Response to Platinum-Based Chemotherapy: Where Do We Stand? | Cancers (Basel) | 2022 | 35740584 | PubTator, text mining | PubMed |
| Epstein-Barr Virus (EBV) Is Mostly Latent and Clonal in Angioimmunoblastic T Cell Lymphoma (AITL). | Cancers (Basel) | 2022 | 35740565 | PubTator, text mining | PubMed |
| Protein Farnesylation on Nasopharyngeal Carcinoma, Molecular Background and Its Potential as a Therapeutic Target. | Cancers (Basel) | 2022 | 35740492 | PubTator, text mining | PubMed |
| Mycobacterium tuberculosis infection drives a type I IFN signature in lung lymphocytes. | Cell Rep | 2022 | 35732116 | PubTator, text mining | PubMed |
| Identification and characterization of virus-encoded circular RNAs in host cells. | Microb Genom | 2022 | 35731570 | PubTator, text mining | PubMed |
| Detection and characterization of latency stage of EBV and histopathological analysis of prostatic adenocarcinoma tissues. | Sci Rep | 2022 | 35729214 | PubTator, text mining | PubMed |
| Design, Synthesis, and Optimization of Macrocyclic Peptides as Species-Selective Antimalaria Proteasome Inhibitors. | J Med Chem | 2022 | 35727231 | PubTator, text mining | PubMed |
| Pan-Cancer Methylated Dysregulation of Long Non-coding RNAs Reveals Epigenetic Biomarkers. | Front Cell Dev Biol | 2022 | 35721492 | PubTator, text mining | PubMed |
| Granzyme K+ CD8 T cells form a core population in inflamed human tissue. | Sci Transl Med | 2022 | 35704599 | PubTator, text mining | PubMed |
| RITA1 drives the growth of bladder cancer cells by recruiting TRIM25 to facilitate the proteasomal degradation of RBPJ. | Cancer Sci | 2022 | 35701858 | PubTator, text mining | PubMed |
| Innate immune receptor signaling induces transient melanoma dedifferentiation while preserving immunogenicity. | J Immunother Cancer | 2022 | 35697379 | PubTator, text mining | PubMed |
| The Genetics of Autoimmune Myositis. | Front Immunol | 2022 | 35693792 | PubTator, text mining | PubMed |
| Bioinformatic Analysis Identifying PSMB 1/2/3/4/6/8/9/10 as Prognostic Indicators in Clear Cell Renal Cell Carcinoma. | Int J Med Sci | 2022 | 35693739 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5698/papers?page=37